Managing patients with heart failure and kidney disease

In this video roundtable, Mikhail Kosiborod, MD, is joined by fellow experts George Bakris, MD, Biykem Bozkurt, MD, PhD, and Javed Butler, MD, for a discussion about the interrelationship between heart failure and kidney disease, and practice considerations that can help improve patient outcomes.

Video 1: The interrelationship between heart failure and kidney disease: physiology, biology, and epidemiology

The panel begins with a discussion around the prevalence of patients who have both heart failure and chronic kidney disease, and how our understanding of the correlation between these two diseases has recently evolved.

Up Next

Video 1: The interrelationship between heart failure and kidney disease: physiology, biology, and epidemiology
Video 2: Disease management and the emergence of agents that benefit both conditions
Video 3: Moving toward a team-based approach

About the Panel

Dr. Kosiborod Photo

Mikhail Kosiborod, MD

  • Professor, Department of Medicine
  • University of Missouri, Kansas City
  • Co-Director, Haverty Cardiometabolic Center of Excellence
  • Saint Luke's Mid America Heart Institute
  • Kansas City, Missouri
Dr. Bakris Photo

George Bakris, MD

  • Professor, Department of Medicine
  • The University of Chicago Pritzker School of Medicine
  • Director, Comprehensive Hypertension Center
  • Department of Medicine, UC Hospitals
  • Chicago, Illinois
Dr. Bozkurt Photo

Biykem Bozkurt, MD, PhD

  • Mary and Gordon Cain Chair
  • Professor, Department of Medicine, Division of Cardiology
  • Winters Center for Heart Failure
  • Associate Provost of Faculty Affairs
  • Senior Associate Dean of Faculty Development
  • Associate Director
  • Cardiovascular Research Institute, Baylor College of Medicine
  • Houston, Texas
Dr. Butler Photo

Javed Butler, MD

  • Professor, Department of Medicine
  • University of Mississippi Medical Center
  • Jackson, Mississippi
Disclosures

Mikhail Kosiborod, MD, has disclosed the following relevant financial relationships:
Received a research grant from: AstraZeneca; Boehringer Ingelheim
Serve(d) as a consultant or a member of an advisory board for: Amgen; Applied Therapeutics; AstraZeneca; Bayer; Boehringer Ingelheim; Eli Lilly; Esperion Therapeutics; Janssen; Merck; Novo Nordisk; Sanofi; Vifor Pharma
Received research support from: AstraZeneca
Received honorarium from: AstraZeneca; Boehringer Ingelheim; Novo Nordisk

George Bakris, MD, has disclosed no relevant financial relationships.

Biykem Bozkurt, MD, PhD, has disclosed the following relevant financial relationships:
Serve(d) as an advisory committee member for: Amgen; sc Pharma; Respicardia
Serve(d) as a Clinical Events Committee member for: Abbott
Serve(d) as a Data and Safety Monitoring Committee member for: LivaNova

Javed Butler, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Abbott; Amgen; Array; AstraZeneca; Bayer; Boehringer-Ingelheim; Bristol-Myers Squibb; CVRx; Janssen; LivaNova; Luitpold; Medtronic; Merck; Novartis; Novo Nordisk; Vifor
Serve(d) as a speaker or a member of a speakers bureau for: AstraZeneca; Novartis; Boehringer-Ingelheim; Eli Lilly; Janssen